02/09 .2021
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
KUALA LUMPUR, Feb. 9 (Xinhua) -- Chinese company Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) signed an agreement on Tuesday with Malaysian public listed company Yong Tai Bhd (YTB) for the procurement, phase three clinical trials and exclusive commercialization of its inactivated COVID-19 vaccine candidate.
12/01 .2020
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
The COVID-19 pandemic likely plunged you into a world ― specifically, the world of vaccine development ― that you didn’t know much about before. Maybe you’ve learned that vaccines typically take years to produce.
12/01 .2020
With global push for COVID-19 vaccines, China aims to win friends and cut deals
The first people in the world to receive a COVID-19 vaccine were not part of a clinical trial. No TV stations or newspapers covered the historic event. No company issued a statement.